NeoRx rhenium monoclonal
Executive Summary
Phase I study of the radioisotope-linked monoclonal antibody has begun at the Virginia Mason Medical Center in Seattle. The rhenium product will be tested against breast, colon and lung cancer. Five patients have been treated to date. Phase II trials are planned for 1989....